FDA Proposes New Disclosure Rules For Panels

Pharmalot -- This is long overdue. In a bid to appear transparent, the agency is issuing a draft guidance that would expand disclosure when a conflict of interest waiver is granted to individuals who participate in its advisory committee meetings.